Study Supports Use of ThyraMIR and the ThyGenX Thyroid Oncogene Panel to Improve Identification of Benign and Malignant Thyroid Nodules
In a multicenter study, the combined platform test by Interpace Diagnostics achieved negative predictive value of 94% and positive predictive value of 74%.
Read More